Delivery Order SPE2DB22D3501-SPE2DB25FXE06
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Loperamide 2 mg capsules in quantities of 500 units. This firm fixed-price, non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg with a ceiling value of $1,299.86 on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is not designated as a set-aside contract and was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,322.07 for 500 capsules of Loperamide 2 mg on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. This $999,999,999.00 prime contract vehicle, which...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $1,596.00, is scheduled for completion by August 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Loperamide 2 mg capsules (100 count) with a ceiling value of $1,067.84. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 20, 2025, with performance occurring at the vendor's Conshohocken location. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $2,803.00 to AmerisourceBergen Drug Corp for the supply of 500 capsules of Loperamide 2 mg, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, a common over-the-counter antidiarrheal medication. This competitively awarded, firm fixed-price contract has a ceiling value of $2,084.56 and an ultimate completion date of August 28, 2025. The delivery order was issued on August 27, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,222,110 units of the 2 mg Loperamide capsule product. The $2,054.95 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corporation serves as the prime contractor and has an existing $999,999,999.00 indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 500 units of Loperamide 2mg tablets, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE06Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,063.67 and an ultimate completion date of September 5, 2025. The contract represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables comprehensive global pharmaceutical support for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated significant capacity in fulfilling federal medical procurement requirements through open competition, delivering a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for gastrointestinal medication represents one of numerous routine pharmaceutical transactions executed through the company's comprehensive DLA contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/4/25 |